A Network Pharmacology Approach and Validation Experiments to Investigate the Mechanism of Wen-Dan Decoction in the Treatment of SINFH


Cite item

Full Text

Abstract

Introduction::Steroid-induced necrosis of the femoral head (SINFH) is a femoral head necrotic disease caused by prolonged use of hormones. Wen-Dan decoction is used in Chinese clinical practice for the treatment of steroid-induced necrosis of the femoral head (SINFH). However, the mechanism and active compounds of Wen-Dan decoction used to treat SINFH are not well understood.

Objectives::We studied the mechanism of action of Wen-Dan decoction in treating steroidinduced necrosis of the femoral head (SINFH) via network pharmacology and in vivo experiments.

Methods::The active compounds of Wen-Dan decoction and SINFH-related target genes were identified through public databases. Then, network pharmacological analysis was conducted to explore the potential key active compounds, core targets and biological processes of Wen-Dan decoction in SINFH. The potential mechanisms of Wen-Dan decoction in SINFH obtained by network pharmacology were validated through in vivo experiments.

Results::We identified 608 DEGs (differentially expressed genes) (230 upregulated, 378 downregulated) in SINFH. GO analysis revealed that the SINFH-related genes were mainly involved in neutrophil activation and the immune response. KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway analysis showed that the SINFH-related genes were mainly associated with cytokine receptor interactions, lipids, atherosclerosis, and tuberculosis. We identified 147 active ingredients of Wen-Dan decoction; the core ingredient was quercetin, and licorice was an active ingredient. Moreover, 277 target genes in the treatment of SINFH with Wen-Dan decoction were identified, and NCF1, PTGS2, and RUNX2 were selected as core target genes. QRT-PCR of peripheral blood from SINFH patients showed higher levels of PGTS2 and NCF1 and showed lower levels of RUNX2 compared to controls. QRT-PCR analysis of peripheral blood and femoral bone tissue from a mouse model of SINFH showed higher levels of PGTS2 and NCF1 and lower levels of RUNX2 in the experimental animals than the controls, which was consistent with the bioinformatics results. HE, immunohistochemistry, and TUNEL staining confirmed a significant reduction in hormone-induced femoral head necrosis in the quercetintreated mice. HE, immunohistochemistry, and TUNEL staining confirmed significant improvement in hormone-induced femoral head necrosis in the quercetin-treated mice.

Conclusion::We provide new insights into the genes and related pathways involved in SINFH and report that PTGS2, RUNX2, and NCF1 are potential drug targets. Quercetin improved SINFH by promoting osteogenesis and inhibiting apoptosis.

About the authors

Baochuang Qi

Graduate School,, Kunming Medical University

Email: info@benthamscience.net

Minzheng Guo

Graduate School,, Kunming Medical University

Email: info@benthamscience.net

Xiangwen Shi

Graduate School,, Kunming Medical University

Email: info@benthamscience.net

Mingjun Li

Graduate school, Kunming Medical University

Email: info@benthamscience.net

Yipeng Wu

Department of Orthopaedic, 920th Hospital of Joint Logistics Support Force of PLA

Email: info@benthamscience.net

Yi Wang

Department of Orthopedics,, 920th Hospital of Joint Logistics Support Force of PLA

Email: info@benthamscience.net

Qian Lv

Department of Orthopaedic, 920th Hospital of Joint Logistics Support Force of PLA

Email: info@benthamscience.net

Xinyu Fan

Department of Orthopaedic, 920th Hospital of Joint Logistics Support Force of PLA

Email: info@benthamscience.net

Chuan Li

Department of Orthopaedic, 920th Hospital of Joint Logistics Support Force of PLA

Author for correspondence.
Email: info@benthamscience.net

Yongqing Xu

Department of Orthopaedic, 920th Hospital of Joint Logistics Support Force of PLA

Author for correspondence.
Email: info@benthamscience.net

References

  1. Zhang, Q.Y.; Li, Z.R.; Gao, F.Q.; Sun, W. Pericollapse stage of osteonecrosis of the femoral head: A last chance for joint preservation. Chin. Med. J. (Engl.), 2018, 131(21), 2589-2598. doi: 10.4103/0366-6999.244111 PMID: 30381593
  2. Song, Y.; Du, Z.; Ren, M.; Yang, Q.; Wang, Q.; Chen, G.; Zhao, H.; Li, Z.; Wang, J.; Zhang, G. Association of gene variants of transcription factors PPARγ, RUNX2, Osterix genes and COL2A1, IGFBP3 genes with the development of osteonecrosis of the femoral head in Chinese population. Bone, 2017, 101, 104-112. doi: 10.1016/j.bone.2017.05.002 PMID: 28476574
  3. Seamon, J.; Keller, T.; Saleh, J.; Cui, Q. The pathogenesis of nontraumatic osteonecrosis. Arthritis (Egypt), 2012, 2012, 1-11. doi: 10.1155/2012/601763 PMID: 23243507
  4. Ikeuchi, K.; Hasegawa, Y.; Seki, T.; Takegami, Y.; Amano, T.; Ishiguro, N. Epidemiology of nontraumatic osteonecrosis of the femoral head in Japan. Mod. Rheumatol., 2015, 25(2), 278-281. doi: 10.3109/14397595.2014.932038 PMID: 25036228
  5. Vardhan, H.; Tripathy, S.K.; Sen, R.K.; Aggarwal, S.; Goyal, T. Epidemiological profile of femoral head osteonecrosis in the north Indian population. Indian J. Orthop., 2018, 52(2), 140-146. doi: 10.4103/ortho.IJOrtho_292_16 PMID: 29576641
  6. Petek, D.; Hannouche, D.; Suva, D. Osteonecrosis of the femoral head: pathophysiology and current concepts of treatment. EFORT Open Rev., 2019, 4(3), 85-97. doi: 10.1302/2058-5241.4.180036 PMID: 30993010
  7. Wang, A.; Ren, M.; Wang, J. The pathogenesis of steroid-induced osteonecrosis of the femoral head: A systematic review of the literature. Gene, 2018, 671, 103-109. doi: 10.1016/j.gene.2018.05.091 PMID: 29859289
  8. Zhao, D.; Liu, F.; Wang, W.; Yang, L.; Wang, B.; Wang, J.; Chai, W. An epidemiological study of etiology and clinical characteristics in patients with nontraumatic osteonecrosis of the femoral head. J. Res. Med. Sci., 2017, 22(1), 15. doi: 10.4103/1735-1995.200273 PMID: 28458706
  9. Arbab, D.; König, D.P. Atraumatic femoral head necrosis in adults. Dtsch. Arztebl. Int., 2016, 113(3), 31-38. doi: 10.3238/arztebl.2016.0031 PMID: 26857510
  10. Yu, T.; Xie, L.M.; Zhang, Z.N.; Ke, X.; Liu, Y. Study on the Distribution of Constitutions of Chinese Medicine in Patients with Osteonecrosis of Femoral Head. Chung Kuo Chung Hsi I Chieh Ho Tsa Chih, 2016, 36(6), 659-662. PMID: 27491221
  11. Yu, T.; Zhang, Z.; Xie, L.; Ke, X.; Liu, Y. The influence of traditional Chinese medicine constitutions on the potential repair capacity after osteonecrosis of the femoral head. Complement. Ther. Med., 2016, 29, 89-93. doi: 10.1016/j.ctim.2016.09.010 PMID: 27912962
  12. Yang, C.; Wang, J.; Chen, L.; Xu, T.; Ming, R.; Hu, Z.; Fang, L.; Wang, X.; Li, Q.; Sun, C.; Liu, C.; Lin, N. Tongluo Shenggu capsule promotes angiogenesis to ameliorate glucocorticoid-induced femoral head necrosis via upregulating VEGF signaling pathway. Phytomedicine, 2023, 110, 154629. doi: 10.1016/j.phymed.2022.154629 PMID: 36608500
  13. Zhang, Y.; Liu, T.; Zhang, L.; Pu, Z.; Yan, Z.; Hua, H. Wendan decoction in the treatment of nonalcoholic fatty liver disease: A systematic review and meta-analysis. Front. Pharmacol., 2022, 13, 1039611. doi: 10.3389/fphar.2022.1039611 PMID: 36324682
  14. Feng, W.; Ye, X.; Lv, H.; Hou, C.; Chen, Y. Wendan decoction for dyslipidemia. Medicine (Baltimore), 2019, 98(3), e14159. doi: 10.1097/MD.0000000000014159 PMID: 30653157
  15. Lan, T.H.; Zhang, L.L.; Wang, Y.H.; Wu, H.L.; Xu, D.P. Systems pharmacology dissection of traditional Chinese medicine Wen-Dan decoction for treatment of cardiovascular diseases. Evid. Based Complement. Alternat. Med., 2018, 2018, 1-14. doi: 10.1155/2018/5170854 PMID: 29861771
  16. Zhang, G.; Yang, G.; Deng, Y.; Zhao, X.; Yang, Y.; Rao, J.; Wang, W.; Liu, X.; He, J.; Lv, L. Ameliorative effects of Xue-Fu-Zhu-Yu decoction, Tian-Ma-Gou-Teng-Yin and Wen-Dan decoction on myocardial fibrosis in a hypertensive rat mode. BMC Complement. Altern. Med., 2015, 16(1), 56. doi: 10.1186/s12906-016-1030-3 PMID: 26852136
  17. Li, Z.Y. Clinical Study of Manipulation Combined with Wen dan Decoction in the Treatment of Steroid-Induced Femur Head Necrosis (Bone Ero-sion Phlegm-Dampness Syndrome), doi: 10.26980/d.cnki.gcczc.2021.000265
  18. Tian, H.; Guan, D.; Li, J. Identifying osteosarcoma metastasis associated genes by weighted gene co-expression network analysis (WGCNA). Medicine (Baltimore), 2018, 97(24), e10781. doi: 10.1097/MD.0000000000010781 PMID: 29901575
  19. Ito, K.; Murphy, D. Application of ggplot2 to pharmacometric graphics. CPT Pharmacometrics Syst. Pharmacol., 2013, 2(10), 79. doi: 10.1038/psp.2013.56 PMID: 24132163
  20. Zeng, J.; Deng, P.; Li, J.; Feng, W.; Chen, J.; Zeng, Y. Increased serum protein levels by Yuanshi Shengmai Chenggu Tablet in treatment of avascular osteonecrosis of the femoral head. Mol. Med. Rep., 2017, 17(2), 2121-2126. doi: 10.3892/mmr.2017.8119 PMID: 29207081
  21. Cohen-Rosenblum, A.; Cui, Q. Osteonecrosis of the femoral head. Orthop. Clin. North Am., 2019, 50(2), 139-149. doi: 10.1016/j.ocl.2018.10.001 PMID: 30850073
  22. Cui, Q.; Jo, W.L.; Koo, K.H.; Cheng, E.Y.; Drescher, W.; Goodman, S.B.; Ha, Y.C.; Hernigou, P.; Jones, L.C.; Kim, S.Y.; Lee, K.S.; Lee, M.S.; Lee, Y.J.; Mont, M.A.; Sugano, N.; Taliaferro, J.; Yamamoto, T.; Zhao, D. ARCO consensus on the pathogenesis of non-traumatic osteonecrosis of the femoral head. J. Korean Med. Sci., 2021, 36(10), e65. doi: 10.3346/jkms.2021.36.e65 PMID: 33724736
  23. Lan, D.; Qi, S.; Yao, C.; Li, X.; Liu, H.; Wang, D.; Wang, Y. Quercetin protects rat BMSCs from oxidative stress via ferroptosis. J. Mol. Endocrinol., 2022, 69(3), 401-413. doi: 10.1530/JME-22-0086 PMID: 35900382
  24. Lesjak, M.; Beara, I.; Simin, N.; Pintać, D.; Majkić, T.; Bekvalac, K.; Orčić, D.; Mimica-Dukić, N. Antioxidant and anti-inflammatory activities of quercetin and its derivatives. J. Funct. Foods, 2018, 40, 68-75. doi: 10.1016/j.jff.2017.10.047
  25. Wong, S.K.; Chin, K.Y.; Ima-Nirwana, S. Quercetin as an agent for protecting the bone: A review of the current evidence. Int. J. Mol. Sci., 2020, 21(17), 6448. doi: 10.3390/ijms21176448 PMID: 32899435
  26. Guo, H.; Yin, W.; Zou, Z.; Zhang, C.; Sun, M.; Min, L.; Yang, L.; Kong, L. Quercitrin alleviates cartilage extracellular matrix degradation and delays ACLT rat osteoarthritis development: An in vivo and in vitro study. J. Adv. Res., 2021, 28, 255-267. doi: 10.1016/j.jare.2020.06.020 PMID: 33364061
  27. Satué, M.; Arriero, M.M.; Monjo, M.; Ramis, J.M. Quercitrin and Taxifolin stimulate osteoblast differentiation in MC3T3-E1 cells and inhibit osteoclastogenesis in RAW 264.7 cells. Biochem. Pharmacol., 2013, 86(10), 1476-1486. doi: 10.1016/j.bcp.2013.09.009 PMID: 24060614
  28. Guo, C.; Yang, R.J.; Jang, K.; Zhou, X.; Liu, Y. Protective effects of pretreatment with quercetin against lipopolysaccharide-induced apoptosis and the inhibition of osteoblast differentiation via the MAPK and Wnt/β-catenin pathways in MC3T3-E1 cells. Cell. Physiol. Biochem., 2017, 43(4), 1547-1561. doi: 10.1159/000481978 PMID: 29035884
  29. Li, M.; Zhang, W.; Zhang, J.; Li, X.; Zhang, F.; Zhu, W.; Meng, L.; Holmdahl, R.; Lu, S. Ncf1 governs immune niches in the lung to mediate pulmonary inflammation in mice. Front. Immunol., 2021, 12, 783944. doi: 10.3389/fimmu.2021.783944 PMID: 34970267
  30. Sun, F.; Zhou, J.; Liu, Z.; Jiang, Z.; Peng, H. Dexamethasone induces ferroptosis via P53/SLC7A11/GPX4 pathway in glucocorticoid-induced osteonecrosis of the femoral head. Biochem. Biophys. Res. Commun., 2022, 602, 149-155. doi: 10.1016/j.bbrc.2022.02.112 PMID: 35276555
  31. Zhu, L.; Yang, F.; Wang, L.; Dong, L.; Huang, Z.; Wang, G.; Chen, G.; Li, Q. Identification the ferroptosis-related gene signature in patients with esophageal adenocarcinoma. Cancer Cell Int., 2021, 21(1), 124. doi: 10.1186/s12935-021-01821-2 PMID: 33602233
  32. Jin, Z.; Ren, J.; Qi, S. RETRACTED: Human bone mesenchymal stem cells-derived exosomes overexpressing microRNA-26a-5p alleviate osteoarthritis via down-regulation of PTGS2. Int. Immunopharmacol. 78C (2019) 105946 Int. Immunopharmacol., 2020, 78, 105946. doi: 10.1016/j.intimp.2019.105946 PMID: 31784400
  33. Fang, Y.; Liu, J.; Xin, L.; Wen, J.; Guo, J.; Huang, D.; Li, X. Exploration of the immuno-inflammatory potential targets of xinfeng capsule in patients with ankylosing spondylitis based on data mining, network pharmacology, and molecular docking. Evid. Based Complement. Alternat. Med., 2022, 2022, 1-10. doi: 10.1155/2022/5382607 PMID: 35368759
  34. Chou, L.Y.; Chen, C.H.; Chuang, S.C.; Cheng, T.L.; Lin, Y.H.; Chou, H.C.; Fu, Y.C.; Wang, Y.H.; Wang, C.Z. Discoidin domain receptor 1 regulates Runx2 during osteogenesis of osteoblasts and promotes bone ossification via phosphorylation of p38. Int. J. Mol. Sci., 2020, 21(19), 7210. doi: 10.3390/ijms21197210 PMID: 33003599
  35. Takahata, Y.; Hagino, H.; Kimura, A.; Urushizaki, M.; Kobayashi, S.; Wakamori, K.; Fujiwara, C.; Nakamura, E.; Yu, K.; Kiyonari, H.; Bando, K.; Murakami, T.; Komori, T.; Hata, K.; Nishimura, R. Smoc1 and Smoc2 regulate bone formation as downstream molecules of Runx2. Commun. Biol., 2021, 4(1), 1199. doi: 10.1038/s42003-021-02717-7 PMID: 34667264
  36. Qin, X.; Jiang, Q.; Komori, H.; Sakane, C.; Fukuyama, R.; Matsuo, Y.; Ito, K.; Miyazaki, T.; Komori, T. RUNT‐RELATED TRANSCRIPTION FACTOR‐2 (RUNX2) is required for bone matrix protein gene expression in committed osteoblasts in mice. J. Bone Miner. Res., 2021, 36(10), 2081-2095. doi: 10.1002/jbmr.4386 PMID: 34101902
  37. Xing, L.; Geng, Y.; Li, W.; Lin, L.; Xu, P. Expression of RUNX2/LAPTM5 in MC3T3-E1 osteoblastic cells with induced mineralization. Nan Fang Yi Ke Da Xue Xue Bao, 2021, 41(9), 1394-1399. doi: 10.12122/j.issn.1673-4254.2021.09.15 PMID: 34658355
  38. Song, Q.; Yong, H.M.; Yang, L.V.L.; Liang, Y.Q.; Liu, Z.X.; Niu, D.S.; Bai, Z.G. Lycium barbarum polysaccharide protects against osteonecrosis of femoral head via regulating Runx2 expression. Injury, 2022, 53(4), 1361-1367. doi: 10.1016/j.injury.2021.12.056 PMID: 35082056
  39. Zhang, X.; Li, H.; Chen, F.; Chen, Y.; Chai, Y.; Liao, J.; Gan, B.; Chen, D.; Li, S.; Liu, Y. Icariin regulates miR-23a-3p-mediated osteogenic differentiation of BMSCs via BMP-2/Smad5/Runx2 and WNT/β-catenin pathways in osteonecrosis of the femoral head. Saudi Pharm. J., 2021, 29(12), 1405-1415. doi: 10.1016/j.jsps.2021.10.009 PMID: 35002378
  40. Jiang, X.; Chen, W.; Su, H.; Shen, F.; Xiao, W.; Sun, W. Puerarin facilitates osteogenesis in steroid-induced necrosis of rabbit femoral head and osteogenesis of steroid-induced osteocytes via miR-34a upregulation. Cytokine, 2021, 143, 155512. doi: 10.1016/j.cyto.2021.155512 PMID: 33824083
  41. Zhang, J.; Huang, C.; Liu, Z.; Ren, S.; Shen, Z.; Han, K.; Xin, W.; He, G.; Liu, J. Screening of Potential Biomarkers in the Peripheral Serum for Steroid-Induced Osteonecrosis of the Femoral Head Based on WGCNA and Machine Learning Algorithms. Dis. Markers, 2022, 2022, 1-17. doi: 10.1155/2022/2639470 PMID: 35154510
  42. Jin, S.; Meng, C.; He, Y.; Wang, X.; Zhang, Q.; Wang, Z.; Huang, W.; Wang, H. Curcumin prevents osteocyte apoptosis by inhibiting M1‐type macrophage polarization in mice model of glucocorticoid‐associated osteonecrosis of the femoral head. J. Orthop. Res., 2020, 38(9), 2020-2030. doi: 10.1002/jor.24619 PMID: 32009245
  43. Li, Q.; Zhong, J.; Luo, H.; Urbonaviciute, V.; Xu, Z.; He, C.; Holmdahl, R. Two major genes associated with autoimmune arthritis, Ncf1 and Fcgr2b, additively protect mice by strengthening T cell tolerance. Cell. Mol. Life Sci., 2022, 79(9), 482. doi: 10.1007/s00018-022-04501-0 PMID: 35963953
  44. Gong, Z.; Li, Q.; Shi, J.; Wei, J.; Li, P.; Chang, C.H.; Shultz, L.D.; Ren, G. Lung fibroblasts facilitate pre-metastatic niche formation by remodeling the local immune microenvironment. Immunity, 2022, 55(8), 1483-1500.e9. doi: 10.1016/j.immuni.2022.07.001 PMID: 35908547
  45. Gong, Z.; Li, Q.; Shi, J.; Li, P.; Hua, L.; Shultz, L.D.; Ren, G. Immunosuppressive reprogramming of neutrophils by lung mesenchymal cells promotes breast cancer metastasis. Sci. Immunol., 2023, 8(80), eadd5204. doi: 10.1126/sciimmunol.add5204 PMID: 36800412
  46. Zhang, C.; Xu, X.; Trotter, T.N.; Gowda, P.S.; Lu, Y.; Suto, M.J.; Javed, A.; Murphy-Ullrich, J.E.; Li, J.; Yang, Y. Runx2 deficiency in osteoblasts promotes myeloma resistance to bortezomib by increasing TSP-1–dependent TGFβ1 activation and suppressing immunity in bone marrow. Mol. Cancer Ther., 2022, 21(2), 347-358. doi: 10.1158/1535-7163.MCT-21-0310 PMID: 34907087
  47. Amevor, F.K.; Cui, Z.; Du, X.; Ning, Z.; Deng, X.; Xu, D.; Shu, G.; Wu, Y.; Cao, X.; Shuo, W.; Tian, Y.; Li, D.; Wang, Y.; Zhang, Y.; Du, X.; Zhu, Q.; Han, X.; Zhao, X. Supplementation of dietary quercetin and vitamin e promotes the intestinal structure and immune barrier integrity in aged breeder hens. Front. Immunol., 2022, 13, 860889. doi: 10.3389/fimmu.2022.860889 PMID: 35386687
  48. Li, J.; Sun, Z.; Luo, G.; Wang, S.; Cui, H.; Yao, Z.; Xiong, H.; He, Y.; Qian, Y.; Fan, C. Quercetin attenuates trauma-induced heterotopic ossification by tuning immune cell infiltration and related inflammatory insult. Front. Immunol., 2021, 12, 649285. doi: 10.3389/fimmu.2021.649285 PMID: 34093537
  49. Li, Z.; Li, D.; Chen, R.; Gao, S.; Xu, Z.; Li, N. Cell death regulation: A new way for natural products to treat osteoporosis. Pharmacol. Res., 2023, 187, 106635. doi: 10.1016/j.phrs.2022.106635 PMID: 36581167

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bentham Science Publishers